Mounjaro and Ozempic prices surge amid high demand
The cost of diabetes and weight-loss drugs Mounjaro and Ozempic has surged, sparking concerns over affordability and market competition. Experts weigh in on the implications.
The cost of diabetes and weight-loss drugs Mounjaro and Ozempic has surged, sparking concerns over affordability and market competition. Experts weigh in on the implications.
Popular diabetes and weight-loss drugs Ozempic and Mounjaro face price hikes as Trump-era tariffs on Chinese imports take effect. Experts warn of potential shortages and financial strain on patients.
Stock markets surge, oil prices rise, and Ukrainian President Zelenskyy holds talks with Donald Trump amid Jackson Hole summit anticipation. UK house prices dip in August.
A rediscovered 1985 IKEA flyer shows astonishingly low prices for furniture and home goods, sparking nostalgia and disbelief among shoppers today.
Pharmaceutical giant Eli Lilly announces a significant price increase for its diabetes and weight-loss drug Mounjaro in the UK, sparking concerns over affordability and access.
Former Florida Attorney General Pam Bondi faces ethics complaints for allegedly lobbying the Justice Department on behalf of a pharmaceutical company while serving on a federal drug enforcement board.
A pharmaceutical executive faces charges after a horrific wrong-way collision claimed the life of a former Olympic swimmer. The shocking incident has sent shockwaves through the community.
The pharmaceutical giant behind Mounjaro unveils an ambitious initiative to combat obesity in the UK, offering hope for millions struggling with weight-related health issues.
Global markets react to easing tensions in Ukraine, with oil and gold prices retreating. Meanwhile, the iconic Fabergé brand changes hands in a major acquisition.
Pharmaceutical giant Eli Lilly is developing an oral weight loss drug that may compete with injectable treatments like Wegovy. Early trials show promising results, potentially offering a more convenient alternative for patients.
Delhi authorities have busted a massive counterfeit drug operation, with fake versions of Johnson & Johnson and GSK products seized. The racket poses serious health risks to consumers.
The US Food and Drug Administration (FDA) has approved a new Alzheimer's treatment, sparking debate over its efficacy and high cost while offering hope to millions.
Shares in major European pharmaceutical firms plummet as investors react to potential US tariffs, sparking market volatility and sector-wide uncertainty.
Sales of Novo Nordisk's blockbuster diabetes medications, including Ozempic, have dropped unexpectedly. Experts weigh in on the causes and future implications.
Former US President Donald Trump has floated the idea of imposing tariffs on imported pharmaceuticals, a move that could significantly impact the UK's healthcare sector and drug prices.
Former President Donald Trump’s controversial proposal to slash drug prices has reignited tensions with pharmaceutical giants. Critics warn of risks to innovation, while advocates hail it as a win for patients.
Rising accommodation prices and soaring production costs threaten the future of Edinburgh Fringe, leaving performers questioning if the world's largest arts festival is still viable.
A US expat living in Britain was stunned by the affordability of Poundland, comparing prices to what he'd pay back home. His viral TikTok reaction highlights the cost-of-living differences between the two countries.
House prices in the UK have fallen at the fastest annual rate since 2009, with Nationwide reporting a 3.8% decline. High mortgage rates and inflation continue to squeeze buyers.
A shocking divide in the US housing market reveals some areas suffering steep price drops while others see unprecedented surges. Discover the regions hit hardest and those defying the trend.
Rising food inflation in the UK is driving up costs for barbecue staples like burgers, sausages, and chicken, squeezing household budgets during peak grilling season.
Premier League supporters are outraged as new kit prices for the 2024/25 season hit record highs, with some shirts costing over £100. Discover which clubs are charging the most and why fans are threatening boycotts.
Labour leader Keir Starmer vows to confront pharmaceutical giants over soaring drug prices, promising relief for the NHS and patients. Will his strategy work?
Former US President Donald Trump calls on British pharmaceutical companies to reduce drug prices for the NHS, sparking debate on healthcare affordability.
Thinking of upgrading to double glazing? Our comprehensive guide breaks down the costs, benefits, and key considerations for UK homeowners in 2024.
New data exposes the UK areas paying the highest energy prices, with some households facing bills nearly £1,000 above the national average.
UK house prices rebounded in July following a slight decline in June, according to Nationwide. Discover the latest trends and what experts say about the market's resilience.
A shocking comparison shows how property prices in certain US states mirror those in London's Tube zones, revealing surprising affordability overseas.
New US tariffs could drastically increase the cost of essential medicines in Australia, putting the Pharmaceutical Benefits Scheme at risk. Experts warn of dire consequences for patients.
Biotech leader Moderna announces major layoffs, axing 150 jobs as part of a strategic cost-reduction plan. What does this mean for the future of mRNA vaccines?